Related references
Note: Only part of the references are listed.Alzheimer-associated Aβ oligomers impact the central nervous system to induce peripheral metabolic deregulation
Julia R. Clarke et al.
EMBO MOLECULAR MEDICINE (2015)
Hyperglycemia modulates extracellular amyloid-β concentrations and neuronal activity in vivo
Shannon L. Macauley et al.
JOURNAL OF CLINICAL INVESTIGATION (2015)
Inflammation, Defective Insulin Signaling, and Mitochondrial Dysfunction as Common Molecular Denominators Connecting Type 2 Diabetes to Alzheimer Disease
Fernanda G. De Felice et al.
DIABETES (2014)
Hydrogen Sulfide Alleviates Diabetic Nephropathy in a Streptozotocin-induced Diabetic Rat Model
Xiang Zhou et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Impaired glycemia increases disease progression in mild cognitive impairment
Jill K. Morris et al.
NEUROBIOLOGY OF AGING (2014)
Intranasal deferoxamine reverses iron-induced memory deficits and inhibits amyloidogenic APP processing in a transgenic mouse model of Alzheimer's disease
Chuang Guo et al.
NEUROBIOLOGY OF AGING (2013)
Decoding Alzheimer's disease from perturbed cerebral glucose metabolism: Implications for diagnostic and therapeutic strategies
Zhichun Chen et al.
PROGRESS IN NEUROBIOLOGY (2013)
Glucose Intolerance, Insulin Resistance, and Pathological Features of Alzheimer Disease in the Baltimore Longitudinal Study of Aging
Madhav Thambisetty et al.
JAMA NEUROLOGY (2013)
Amelioration of neurodegenerative changes in cellular and rat models of diabetes-related Alzheimer's disease by exendin-4
Song Chen et al.
AGE (2012)
Increased Aβ production prompts the onset of glucose intolerance and insulin resistance
Margarita Jimenez-Palomares et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2012)
Intranasal Insulin Therapy for Alzheimer Disease and Amnestic Mild Cognitive Impairment A Pilot Clinical Trial
Suzanne Craft et al.
ARCHIVES OF NEUROLOGY (2012)
Contribution of genetic and dietary insulin resistance to Alzheimer phenotype in APP/PS1 transgenic mice
Mikko Hiltunen et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2012)
An anti-diabetes agent protects the mouse brain from defective insulin signaling caused by Alzheimer's disease-associated Aβ oligomers
Theresa R. Bomfim et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
AGEs/RAGE complex upregulates BACE1 via NF-kappa B pathway activation
Michela Guglielmotto et al.
NEUROBIOLOGY OF AGING (2012)
Risk of developing dementia in people with diabetes and mild cognitive impairment
Latha Velayudhan et al.
BRITISH JOURNAL OF PSYCHIATRY (2010)
Brain Expression of Cre Recombinase Driven by Pancreas-Specific Promoters
Junghun Song et al.
GENESIS (2010)
Insulin deficiency exacerbates cerebral amyloidosis and behavioral deficits in an Alzheimer transgenic mouse model
Xu Wang et al.
MOLECULAR NEURODEGENERATION (2010)
Beta amyloid and hyperphosphorylated tau deposits in the pancreas in type 2 diabetes
Judith Miklossy et al.
NEUROBIOLOGY OF AGING (2010)
Immunohistochemical analysis of human brain suggests pathological synergism of Alzheimer's disease and diabetes mellitus
Tony Valente et al.
NEUROBIOLOGY OF DISEASE (2010)
Permissive Role of Insulin in the Expression of Long-Term Potentiation in the Hippocampus of Immature Rats
Wenchao Zhao et al.
NEUROSIGNALS (2010)
Diabetes-accelerated memory dysfunction via cerebrovascular inflammation and Aβ deposition in an Alzheimer mouse model with diabetes
Shuko Takeda et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Mechanisms of tau-induced neurodegeneration
Khalid Iqbal et al.
ACTA NEUROPATHOLOGICA (2009)
Insulin resistance and Alzheimer's disease
Suzanne M. de la Monte
BMB REPORTS (2009)
Mid- and Late-Life Diabetes in Relation to the Risk of Dementia A Population-Based Twin Study
Weili Xu et al.
DIABETES (2009)
Multiple levels of regulation determine the role of the receptor for AGE (RAGE) as common soil in inflammation, immune responses and diabetes mellitus and its complications
A. Bierhaus et al.
DIABETOLOGIA (2009)
Increased Tau Phosphorylation and Cleavage in Mouse Models of Type 1 and Type 2 Diabetes
Bhumsoo Kim et al.
ENDOCRINOLOGY (2009)
Insulin Receptor Dysfunction Impairs Cellular Clearance of Neurotoxic Oligomeric Aβ
Wei-Qin Zhao et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
The β-Secretase Enzyme BACE in Health and Alzheimer's Disease: Regulation, Cell Biology, Function, and Therapeutic Potential
Robert Vassar et al.
JOURNAL OF NEUROSCIENCE (2009)
β-Amyloid deposition in brains of subjects with diabetes
I. Alafuzoff et al.
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2009)
Protection of synapses against Alzheimer's-linked toxins: Insulin signaling prevents the pathogenic binding of Aβ oligomers
Fernanda G. De Felice et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Decreased glucose transporters correlate to abnormal hyperphosphorylation of tau in Alzheimer disease
Ying Liu et al.
FEBS LETTERS (2008)
Phosphorylated PP2A (tyrosine 307) is associated with Alzheimer neurofibrillary pathology
R. Liu et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2008)
Glycogen synthase kinase-3 inhibition is integral to long-term potentiation
Claudie Hooper et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2007)
The effect of borderline diabetes on the risk of dementia and Alzheimer's disease
Weili Xu et al.
DIABETES (2007)
Effects of sodium ferulate on amyloid-beta-induced MKK3/MKK6-p38 MAPK-Hsp27 signal pathway and apoptosis in rat hippocampus
Ying Jin et al.
ACTA PHARMACOLOGICA SINICA (2006)
The effect of insulin deficiency on tau and neurofilament in the insulin knockout mouse
R Schechter et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2005)
Secreted beta-amyloid precursor protein activates microglia via JNK and p38-MAPK
AM Bodles et al.
NEUROBIOLOGY OF AGING (2005)
Increased risk of type 2 diabetes in Alzheimer disease
J Janson et al.
DIABETES (2004)
The glamour and gloom of glycogen synthase kinase-3
RS Jope et al.
TRENDS IN BIOCHEMICAL SCIENCES (2004)
Diabetes, impaired fasting glucose, and development of cognitive impairment in older women
K Yaffe et al.
NEUROLOGY (2004)
Pathways towards and away from Alzheimer's disease
MP Mattson
NATURE (2004)
RAGE potentiates Aβ-induced perturbation of neuronal function in transgenic mice
O Arancio et al.
EMBO JOURNAL (2004)
RAGE mediates amyloid-β peptide transport across the blood-brain barrier and accumulation in brain
R Deane et al.
NATURE MEDICINE (2003)
Increased islet apoptosis in Pdx1+/- mice
JD Johnson et al.
JOURNAL OF CLINICAL INVESTIGATION (2003)
Insulin-degrading enzyme regulates the levels of insulin, amyloid β-protein, and the β-amyloid precursor protein intracellular domain in vivo
W Farris et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Reduction in pancreatic transcription factor PDX-1 impairs glucose-stimulated insulin secretion
M Brissova et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Pancreatic duodenal homeobox-1, PDX-1, a major regulator of beta cell identity and function
CM McKinnon et al.
DIABETOLOGIA (2001)
Involvement of microglial receptor for advanced glycation endproducts (RAGE) in Alzheimer's disease: Identification of a cellular activation mechanism
LF Lue et al.
EXPERIMENTAL NEUROLOGY (2001)
Requirement for p38 and p44/p42 mitogen-activated protein kinases in RAGE-mediated nuclear factor-κB transcriptional activation and cytokine secretion
CH Yeh et al.
DIABETES (2001)
Pancreatic homeodomain transcription factor IDX1/IPF1 expressed in developing brain regulates somatostatin gene transcription in embryonic neural cells
PT Schwartz et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Alzheimer disease and vascular dementia: Relationships with fasting glucose and insulin levels
M Carantoni et al.
DEMENTIA AND GERIATRIC COGNITIVE DISORDERS (2000)
Inflammation and Alzheimer's disease
H Akiyama et al.
NEUROBIOLOGY OF AGING (2000)
Share Paper
